Clinical Trial Update: Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intensity-modulated radiation therapy and paclitaxel with or without pazopanib for anaplastic thyroid carcinoma has completed with post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Pazopanib (Pazopanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Thyroid Gland Anaplastic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-05-14